Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.92 Billion | USD 4.20 Billion | 9.1% | 2023 |
The global Immunohematology market size was worth around USD 1.92 billion in 2023 and is predicted to grow to around USD 4.20 billion by 2032 with a compound annual growth rate (CAGR) of roughly 9.1% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The report covers a forecast and an analysis of the Immunohematology market on a global and regional level.
Immunohematology is the study of antibodies and RBC antigens that are mainly associated with blood transfusion. The basic principle of immunohematology is the reaction between antigens and antibodies, which either causes hemolysis or RBC agglutination. This is used to detect the presence of a particular antigen in the blood.
As per the NCBI, about 250,000 children suffer from sickle cell anemia every year. According to the CDC, about 100,000 people in the U.S. suffer from sickle cell disease, which is likely to increase in the upcoming years. This growing prevalence of blood-related diseases, such as sickle cell disease, is leading to an increase in the demand for blood transfusion procedures. This, in turn, is fueling the global immunohematology market. Additionally, the prevalence of blood cancer is also driving the global immunohematology market, as it requires blood transfusion frequently. Moreover, the increase in accidents worldwide, rise in the number of blood banks and diagnostics centers in developing countries, new product launches for immunohematology, and growth in government funding are further propelling the immunohematology market globally. However, the high cost of analyzers and reagents and the dearth of skilled professionals may limit the global immunohematology market growth.
The study provides a decisive view of the immunohematology market by segmenting it on the basis of product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
Based on products, the immunohematology market is divided into immunohematology analyzers and immunohematology reagents. Immunohematology reagents are anticipated to dominate the market in the future, owing to the increase in research activities and growth in the use of customized reagents for research and diagnostic purposes.
The application segment of the immunohematology market includes blood typing, antibody screening, and others. Antibody screening dominated the market in 2018, owing to its increased use for blood transfusion.
On the basis of end-user, the market includes blood banking, diagnostics and reference laboratories, hospitals, and academic and research institutes.
Report Attributes | Report Details |
---|---|
Report Name | Immunohematology Market |
Market Size in 2023 | USD 1.92 Billion |
Market Forecast in 2032 | USD 4.20 Billion |
Growth Rate | CAGR of 9.1% |
Number of Pages | 110 |
Key Companies Covered | Thermo Fisher Scientific, Bio-Rad Laboratories, IMMUNOCOR, Siemens Healthineers, Ortho Clinical Diagnostics, Grifols, Beckman Coulter, Becton, Dickinson and Company, Abbott Laboratories, and Merck |
Segments Covered | By product, By application, By end-user and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America is projected to dominate the global immunohematology market in the years ahead, owing to the early introduction of highly developed techniques, the presence of a highly skilled workforce, and availability of advanced healthcare infrastructure. The Asia Pacific region is anticipated to be the most lucrative market for immunohematology in the upcoming years, owing to the rising investments and funding by government, the establishment of blood banks and trauma centers in India and China, presence of a large patient pool, and increasing accidents in the region.
Some major players in the global immunohematology market are:
Global Immunohematology Market: Product Analysis
Global Immunohematology Market: Application Analysis
Global Immunohematology Market: End-User Analysis
Global Immunohematology Market: Regional Analysis
FrequentlyAsked Questions
Immunohematology, also known as blood banking or transfusion medicine, is a branch of hematology that studies antigen-antibody reactions and the properties of blood components.
According to study, the Immunohematology market size was worth around USD 1.92 billion in 2023 and is predicted to grow to around USD 4.20 billion by 2032.
The CAGR value of Immunohematology market is expected to be around 9.1% during 2024-2032.
North America has been leading the Immunohematology market and is anticipated to continue on the dominant position in the years to come.
The Immunohematology market is led by players like Thermo Fisher Scientific, Bio-Rad Laboratories, IMMUNOCOR, Siemens Healthineers, Ortho Clinical Diagnostics, Grifols, Beckman Coulter, Becton, Dickinson and Company, Abbott Laboratories, and Merck.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed